New drug combo shows promise for tough head and neck cancers
NCT ID NCT05252429
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 28 times
Summary
This study tests a combination of two drugs, docetaxel and pembrolizumab, in 27 people with head and neck cancer that has come back or spread. The goal is to see if this treatment can shrink tumors and help people live longer. Participants had not received chemotherapy for their advanced cancer before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECT OF DRUG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hokkaido University Hospital
Sapporo, Hokkaido, 0608648, Japan
Conditions
Explore the condition pages connected to this study.